Xuehong Deng
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
62
Citations
1,047
Est. group size
~3
Recurring co-author estimate
Active years
20
Publishing since 2006
Xuehong Deng's work spans gut microbiota and gastrointestinal disorders (such as constipation and irritable bowel syndrome), the effects of probiotics and gut bacteria on digestive health, and traditional Chinese medicine formulations used to protect the heart from injury during reduced blood flow (ischemia). Some studies also touch on drug safety testing and kidney-related treatments like uric acid regulation. The research combines lab-based mechanistic studies (e.g., cell and animal models) with clinical or review-style analyses of treatments.
Output was low and steady (0-2 papers/year) for most of the decade but spiked sharply in 2023 before tapering off in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Bifidobacterium Lactobacillus Triple Viable Alleviates Slow Transit Constipation by Regulating Gut Microbiota and Metabolism
Journal of Gastroenterology and Hepatology · 2025
- Corrigendum: Guanxin Danshen formulation protects against myocardial ischemia reperfusion injury-induced left ventricular remodeling by upregulating estrogen receptor β
Frontiers in Pharmacology · 2024
- A dose-escalation study of HP501, a highly selective URAT1 inhibitor, in male Chinese patients with hyperuricemia
Scientific Reports · 2023
- Intestinal crosstalk between bile acids and microbiota in irritable bowel syndrome
Journal of Gastroenterology and Hepatology · 2023
- Rifaximin Ameliorates Loperamide-Induced Constipation in Rats through the Regulation of Gut Microbiota and Serum Metabolites
Nutrients · 2023
- Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis
Nutrients · 2023
- Notoginsenoside R <sub>1</sub> prevents H9c2 cardiomyocytes apoptosis against hypoxia/reoxygenation <i>via</i> the ERs/PI3K/Akt pathway
RSC Advances · 2018
- Guanxin Danshen Formulation Protects against Myocardial Ischemia Reperfusion Injury-Induced Left Ventricular Remodeling by Upregulating Estrogen Receptor β
Frontiers in Pharmacology · 2017
- [Research progress in epigenetic regulation of myocardial ischemia/ reperfusion injury by traditional Chinese medicine].
PubMed · 2016
- The chronic hepatotoxicity assessment of the herbal formula Zishen Yutai pill
Regulatory Toxicology and Pharmacology · 2016
- Research progress of Guanxin Danshen formula and its effective components in treating coronary artery heart disease
China Journal of Chinese Materia Medica · 2016
- Cancer Research×2
- Nutrients×2
- Journal of Gastroenterology and Hepatology×2
- Frontiers in Pharmacology×2
- iScience×1
- Andrew M. Asberry
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Chang‐Deng Hu
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Bennett D. Elzey
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Rami A. Alfar
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Dipankor Chatterjee
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile